The aim is to improve the research infrastructure in Latin America, with a particular focus on producing anti-infectives and new vaccines against infectious diseases, as well as establishing diagnostics and monitoring for pandemics. That is why we are planning, for example, to establish modern laboratories at universities in Mexico City and Havana,” says Seliger, who is herself an immunologist and specialist in the immunological monitoring of infectious diseases and the development of immunotherapies. Unequal access to vaccinations and diagnostics for infectious diseases, as well as regional aspects, are also among the topics covered by the health center, explains Seliger: “Our concern is that all countries in the world have access to vaccines at a reasonable price. And that vaccines are developed that are easy to administer and do not have to be stored at minus 150 degrees, because that is not possible everywhere
